首页> Cancer investigation> Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors

Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors

导出原文传递

翻译打印收藏纠错

第一作者： Jones,S.F.

作者： Jones,S.F. ^[1] ; Infante,J.R. ^[2] ; Spigel,D.R. ^[3] ; Peacock,N.W. ; Thompson,D.S. ; Greco,F.A. ; McCulloch,W. ; BurrisIiiIII,H.A.

作者单位： Sarah Cannon Research Institute, 250 25th Avenue North, Nashville, TN 37203, United States ^[1] Alba BioPharm Advisors Inc, Raleigh, NC, United States ^[2] Tennessee Oncology, Nashville, TN, United States ^[3]

关键词 Breast cancers Clinical trials Pancreatic cancer

发布时间 2015-02-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Cancer investigation

2012年30卷6期

481-486页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

Cancer investigation

2012年30卷6期

481-486页

检索历史清除

Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors

Cancer investigation

相似文献

同项目论文

Cancer investigation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors

Cancer investigation

相似文献

同项目论文

Cancer investigation

相关期刊

检索历史清除